Anzeige
Mehr »
Freitag, 12.09.2025 - Börsentäglich über 12.000 News
Diese Aktie sichert sich Exklusiv-Partnerschaft mit Babcock für Ukraine-Defence - Neubewertung voraus?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1XCF2 | ISIN: US09062W2044 | Ticker-Symbol: BJX1
Tradegate
12.09.25 | 16:48
22,000 Euro
-3,51 % -0,800
1-Jahres-Chart
BIOLIFE SOLUTIONS INC Chart 1 Jahr
5-Tage-Chart
BIOLIFE SOLUTIONS INC 5-Tage-Chart
RealtimeGeldBriefZeit
21,60022,00023:00
21,60021,80021:56

Aktuelle News zur BIOLIFE SOLUTIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
21.08.BIOLIFE SOLUTIONS INC - 8-K, Current Report1
08.08.BioLife Solutions raises 2025 revenue guidance to $100M-$103M as cell processing momentum accelerates1
08.08.BioLife Solutions Q2 2025: Gewinnziel verfehlt, Umsatzprognose jedoch angehoben2
07.08.BIOLIFE SOLUTIONS INC - 10-Q, Quarterly Report3
07.08.BioLife Solutions GAAP EPS of -$0.33 misses by $0.29, revenue of $25.4M beats by $1.69M3
07.08.BIOLIFE SOLUTIONS INC - 8-K, Current Report-
BIOLIFE SOLUTIONS Aktie jetzt für 0€ handeln
07.08.BioLife Solutions, Inc.: BioLife Solutions Reports Second Quarter 2025 Financial Results75Cell Processing revenue of $23.0 million, up 28% over Q2 2024 GAAP gross margin of 62% and non-GAAP adjusted gross margin of 65% GAAP net loss of $15.8 million...
► Artikel lesen
28.07.BioLife Solutions invests $2 million in stem cell developer Pluristyx1
28.07.BioLife Solutions, Inc.: BioLife Solutions Makes Strategic Investment in Pluristyx158BOTHELL, Wash., July 28, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services...
► Artikel lesen
08.05.BIOLIFE SOLUTIONS INC - 10-Q, Quarterly Report3
08.05.BIOLIFE SOLUTIONS INC - 8-K, Current Report-
08.05.BioLife Solutions, Inc.: BioLife Solutions Reports First Quarter 2025 Financial Results112Cell Processing revenue of $21.6 million, up 33% over Q1 2024 GAAP gross margin of 63% and non-GAAP adjusted gross margin of 66% GAAP net loss of $0.4 million and...
► Artikel lesen
10.04.BioLife Solutions Buying Cryopreservation Solutions Company PanTHERA CryoSolutions1
08.04.BIOLIFE SOLUTIONS INC - 10-K/A, Annual Report1
07.04.BioLife Solutions Acquires PanTHERA CryoSolutions To Enhance Biopreservation For CGT1
07.04.BioLife Solutions acquires PanTHERA CryoSolutions1
07.04.BioLife Solutions, Inc.: BioLife Solutions Acquires PanTHERA CryoSolutions to Advance Leadership as a Pure Play Bioproduction Consumables Company168Strategic acquisition enhances biopreservation media portfolio with novel Ice Recrystallization Inhibitor technology Marks the second acquisition from Bioproduction...
► Artikel lesen
24.03.BIOLIFE SOLUTIONS INC - 8-K, Current Report3
03.03.BioLife Solutions, Inc.: BioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial Results225Cell Processing revenue up 7% sequentially to $20.3 million in the fourth quarter; 2024 Cell Processing revenue up 12% over prior year to $73.5 million GAAP gross...
► Artikel lesen
13.01.BioLife Solutions, Inc.: BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing Operations225Fourth quarter Cell Processing revenue increased 7% sequentially to $20.3 million Unaudited revenue for FY2024 from Cell Processing of $73.5 million, exceeded the...
► Artikel lesen
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1